TipRanks
Go Ultimate55% OFF

Pulmuone Corporate (017810) AI Stock Analysis

Top Page

KR:017810

Pulmuone Corporate

(Korea Exchange:017810)

Select Model
Rating:56Neutral
Price Target:$8,333.00â–²(3.64% Upside)
Action:initiatedcoverage
Date:10/28/26

The score is held back primarily by high leverage and weak technical trend signals (below major moving averages and negative MACD). Offsetting this, fundamentals show a recovery in earnings with improving cash flow, and valuation is supportive with a low P/E and a positive dividend yield.

Positive Factors
Steady Revenue ExpansionSustained revenue expansion indicates continued demand for Pulmuone’s packaged and prepared food portfolio. Durable top-line momentum can support scale, strengthen channel presence, and provide a foundation for earnings growth if the company maintains pricing and cost discipline.
Negative Factors
High Financial LeverageVery high leverage leaves Pulmuone with less balance-sheet flexibility when earnings weaken or financing costs rise. The small equity base relative to assets amplifies financial risk and may constrain investment, distributions, or strategic responses over the next several quarters.

Pulmuone Corporate (017810) vs. SPDR S&P 500 ETF (SPY)

-40%-30%-20%-10%0%10%20%KR:017810-37.71%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
KRW 296.62B
Dividend Yield
1.27%
Average Volume (3M)
24.85K
Price to Earnings (P/E)
10.3
Beta (1Y)
-0.03
Revenue Growth
6.32%
EPS Growth
409.58%
Country
KR
Employees
546
Sector
General
Sector Strength
55
Industry
Packaged Foods

Pulmuone Corporate Business Overview & Revenue Model

Company Description

Pulmuone Co., Ltd. operates as a producer, marketer, and distributor of fresh food products and beverages, serving both the South Korean market and international clientele. Its extensive portfolio includes functional and whole foods, mineral water, a...

Pulmuone Corporate Financial Statement Overview

Summary

Income statement shows steady revenue growth and an earnings rebound (score 62), and cash flow is improving with positive operating cash flow and stronger TTM free cash flow (score 54). However, balance-sheet risk is a major drag (balance sheet score 32) due to very high leverage and limited flexibility, and cash generation is not yet strong enough relative to debt to materially reduce this risk.

Income Statement

62Positive

Balance Sheet

32Negative

Cash Flow

54Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.49T3.38T3.21T2.99T2.84T2.52T
Gross Profit821.17B802.22B814.48B726.67B700.42B656.23B
EBITDA274.64B264.72B268.60B218.46B159.18B173.85B
Net Income43.76B18.09B35.40B9.37B-25.54B13.36B
Balance Sheet
Total Assets2.35T2.35T2.33T2.16T2.05T1.97T
Cash, Cash Equivalents and Short-Term Investments164.54B255.45B285.50B248.25B255.63B271.54B
Total Debt1.40T1.25T1.23T1.19T1.04T931.58B
Total Liabilities1.89T1.90T1.75T1.65T1.50T1.38T
Stockholders Equity168.27B140.61B303.64B317.61B412.26B466.59B
Cash Flow
Free Cash Flow53.83B14.28B74.21B66.16B-52.60B-104.72B
Operating Cash Flow189.23B163.75B172.62B193.58B94.84B118.48B
Investing Cash Flow-96.64B-159.40B-106.74B-147.73B-143.91B-213.85B
Financing Cash Flow-93.31B-44.49B-27.09B-51.04B63.74B117.14B

Pulmuone Corporate Technical Analysis

Technical Analysis SentimentNegative
Last Price8040.00

Price Trends

50DMA8948.60Negative
100DMA9085.20Negative
200DMA10595.87Negative

Market Momentum

MACD-229.21Positive
RSI29.86Positive
STOCH10.17Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:017810, the sentiment is Negative. The current price of 8040.00 is below the 20-day moving average (MA) of 8464.50, below the 50-day MA of 8948.60, and below the 200-day MA of 10595.87, indicating a bearish trend. The MACD of -229.21 indicates Positive momentum. The RSI at 29.86 is Positive, neither overbought nor oversold. The STOCH value of 10.17 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:017810.

Pulmuone Corporate Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

KR:017810 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
KR:027410KR:02741062NeutralKRW 329.24B4.96―3.78%3.05%-21.33%
KR:017810KR:01781056NeutralKRW 296.62B10.31―1.27%6.32%409.58%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
KR:003920KR:00392055NeutralKRW 276.86B24.99―3.50%3.02%-36.91%
KR:005610KR:00561053NeutralKRW 314.89B-33.76―2.57%0.18%-121.34%
KR:084690KR:08469044NeutralKRW 266.83B-3.31―4.24%4.24%-486.28%

* General Sector Average

Performance Comparison

-20%0%20%40%KR:017810KR:003920KR:005610KR:027410KR:084690KR:136480Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
KR:017810 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
KR:017810Pulmuone Corporate8040.00-4867.83-37.71%
KR:003920Namyang Dairy Products Co., Ltd40800.00-10100.19-19.84%
KR:005610SAMLIP38850.00-11342.13-22.60%
KR:027410BGF CO. LTD.3440.00-247.09-6.70%
KR:084690Daesang Holdings Co., Ltd7080.00-1798.89-20.26%
KR:136480Harim Co., Ltd.2625.00-206.99-7.31%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026